PathFree Technologies Corporation

Welcome to PathFree Technologies Corporation!

Welcome to PathFree Technologies Corporation!

Dr. Mike Hansen – BA.2.75 “Centaurus” The New Covid Variant of Concern
News , Posts
Dr. Mike Hansen – BA.2.75 “Centaurus” The New Covid Variant of Concern
COVID-19 deaths rising due to omicron subvariant
News
COVID-19 deaths rising due to omicron subvariant
San Diego County Moves to High Community Risk Level as COVID-19 Hospitalizations and Cases Rise

The high-risk level means that San Diegans who are immunocompromised should consider higher levels of protective measures

By City News Service

With the highly infectious BA.4 and BA.5 subvariants driving up case and hospitalization numbers, San Diego County moved into the “high” COVID-19 activity level Thursday, however, unlike Los Angeles County, no indoor mask-wearing mandate has been announced.

As of Thursday, the average daily rate of COVID-19-positive patients being hospitalized in the county rose to 11.5 per 100,000 residents. That topped the U.S. Centers for Disease Control and Prevention’s threshold for “high” virus activity. The county was previously in the “medium” category.

“San Diegans should take every precaution necessary to slow the spread of COVID-19,” said Cameron Kaiser, County deputy public health officer. “Most San Diegans have been vaccinated, but with this virus, and with the prevalence and infectivity of the new variants, a booster is highly recommended, especially for people who are immunocompromised or have other comorbidities.”

On Thursday, the total number of patients in county hospitals with COVID-19 decreased by three to 395, and those in intensive care units decreased by two to 43 — the highest numbers since early March. A total of 6.6% of all hospital beds in the county are occupied by people with COVID-19.

The total case rate for San Diego County is 383.01 per 100,000 residents.

According to the county’s Health and Human Services Agency, lab-confirmed coronavirus cases remain near 10,000 per week, a number that does not include at-home tests. The HHSA also reported it has also seen an increase in re-infections of San Diegans who have tested positive for COVID-19 several times throughout the pandemic. Prior infection does not necessarily prevent re-infection with some of the newer virus variants, according to national data.

Additionally, hospitalizations for COVID-related illnesses are also on the rise, up 66% in the last 30 days, the HHSA said last week. New ICU admissions rose 68% during that same time frame.

The county reported 1,311 new infections and six deaths related to the virus on Monday, increasing the cumulative totals to 851,528 cases and 5,363 deaths.

Coronavirus

LA COUNTYJUL 13

Return of Mask Mandate Appears Imminent in LA County. Here’s What to Expect

BUSINESSJUL 12

Covid Hospitalizations Have Doubled Since May as Omicron BA.5 Sweeps U.S., But Deaths Remain Low

CORONAVIRUS IN SAN DIEGO COUNTY22 HOURS AGO

Health Experts Urging Caution as COVID-19 Infections, Hospitalizations Spike

Health officials have said that a majority of the deaths occurred in people with at least one underlying health condition, mainly hypertension, diabetes and heart disease.

The county only reports COVID data on Mondays and Thursdays.

This article tagged under:

CORONAVIRUS CORONAVIRUS PANDEMIC CDC

News , Posts
San Diego County Moves to High Community Risk Level as COVID-19 Hospitalizations and Cases Rise

The high-risk level means that San Diegans who are immunocompromised should consider higher levels of protective measures

By City News Service

With the highly infectious BA.4 and BA.5 subvariants driving up case and hospitalization numbers, San Diego County moved into the “high” COVID-19 activity level Thursday, however, unlike Los Angeles County, no indoor mask-wearing mandate has been announced.

As of Thursday, the average daily rate of COVID-19-positive patients being hospitalized in the county rose to 11.5 per 100,000 residents. That topped the U.S. Centers for Disease Control and Prevention’s threshold for “high” virus activity. The county was previously in the “medium” category.

“San Diegans should take every precaution necessary to slow the spread of COVID-19,” said Cameron Kaiser, County deputy public health officer. “Most San Diegans have been vaccinated, but with this virus, and with the prevalence and infectivity of the new variants, a booster is highly recommended, especially for people who are immunocompromised or have other comorbidities.”

On Thursday, the total number of patients in county hospitals with COVID-19 decreased by three to 395, and those in intensive care units decreased by two to 43 — the highest numbers since early March. A total of 6.6% of all hospital beds in the county are occupied by people with COVID-19.

The total case rate for San Diego County is 383.01 per 100,000 residents.

According to the county’s Health and Human Services Agency, lab-confirmed coronavirus cases remain near 10,000 per week, a number that does not include at-home tests. The HHSA also reported it has also seen an increase in re-infections of San Diegans who have tested positive for COVID-19 several times throughout the pandemic. Prior infection does not necessarily prevent re-infection with some of the newer virus variants, according to national data.

Additionally, hospitalizations for COVID-related illnesses are also on the rise, up 66% in the last 30 days, the HHSA said last week. New ICU admissions rose 68% during that same time frame.

The county reported 1,311 new infections and six deaths related to the virus on Monday, increasing the cumulative totals to 851,528 cases and 5,363 deaths.

Coronavirus

LA COUNTYJUL 13

Return of Mask Mandate Appears Imminent in LA County. Here’s What to Expect

BUSINESSJUL 12

Covid Hospitalizations Have Doubled Since May as Omicron BA.5 Sweeps U.S., But Deaths Remain Low

CORONAVIRUS IN SAN DIEGO COUNTY22 HOURS AGO

Health Experts Urging Caution as COVID-19 Infections, Hospitalizations Spike

Health officials have said that a majority of the deaths occurred in people with at least one underlying health condition, mainly hypertension, diabetes and heart disease.

The county only reports COVID data on Mondays and Thursdays.

This article tagged under:

CORONAVIRUS CORONAVIRUS PANDEMIC CDC

”The latest trend gaining momentum in the market is growing advances in breathing devices.”

”The latest trend gaining momentum in the market is growing advances in breathing devices.”

The incubators, inhalators, respirators, resuscitators, and other breathing devices market is poised to grow by $809.74 million during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period.

This report on the incubators, inhalators, respirators, resuscitators, and other breathing devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the increasing number of hospitalizations and surgical treatments, significant rise in demand for breathing devices during pandemic outbreaks, and rising number of new product launches and approvals.

The incubators, inhalators, respirators, resuscitators, and other breathing devices market analysis includes the end-user segment and geographic landscape.

The incubators, inhalators, respirators, resuscitators, and other breathing devices market is segmented as below:

By End-user

  • Healthcare settings
  • Pharmaceutical companies

By Geographical Landscape

  • Europe
  • North America
  • Asia
  • Rest of World (ROW)

This study identifies the growing advances in breathing devices as one of the prime reasons driving the incubators, inhalators, respirators, resuscitators, and other breathing devices market growth during the next few years. Also, the surge in demand for disposable devices and increasing sales of breathing devices through online sales channels will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report covers the following areas:

  • Incubators, inhalators, respirators, resuscitators, and other breathing devices market sizing
  • Incubators, inhalators, respirators, resuscitators, and other breathing devices market forecast
  • Incubators, inhalators, respirators, resuscitators, and other breathing devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, the report provides a detailed analysis of several leading incubators, inhalators, respirators, resuscitators, and other breathing devices market vendors that include 3M Co., Ambu AS, Beurer GmbH, Cardinal Health Inc., DANYANG AIRTECH Co. Ltd., Draegerwerk AG and Co. KGaA, Flexicare Group Ltd., GE Healthcare Inc., Hamilton Medical AG, Honeywell International Inc., HUM GmbH, Koninklijke Philips NV, Laerdal Medical AS, LIFE Corp., Medline Industries Inc., Medtronic Plc, Omron Healthcare Europe BV, Phoenix Medical Systems (P) Ltd., Prestige Ameritech, and Zurich Corp.. Also, the incubators, inhalators, respirators, resuscitators, and other breathing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. The analyst’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

The analyst recognizes the following companies as the key players in the global incubators, inhalators, respirators, resuscitators, and other breathing devices market: 3M Co., Ambu AS, Beurer GmbH, Cardinal Health Inc., DANYANG AIRTECH Co. Ltd., Draegerwerk AG and Co. KGaA, Flexicare Group Ltd., GE Healthcare Inc., Hamilton Medical AG, Honeywell International Inc., HUM GmbH, Koninklijke Philips NV, Laerdal Medical AS, LIFE Corp., Medline Industries Inc., Medtronic Plc, Omron Healthcare Europe BV, Phoenix Medical Systems (P) Ltd., Prestige Ameritech, and Zurich Corp.

Commenting on the report, an analyst said: ”The latest trend gaining momentum in the market is growing advances in breathing devices.”

According to the report, one of the major drivers for this market is the increasing number of hospitalizations and surgical treatments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Corporate , News , Posts
”The latest trend gaining momentum in the market is growing advances in breathing devices.”

”The latest trend gaining momentum in the market is growing advances in breathing devices.”

The incubators, inhalators, respirators, resuscitators, and other breathing devices market is poised to grow by $809.74 million during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period.

This report on the incubators, inhalators, respirators, resuscitators, and other breathing devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the increasing number of hospitalizations and surgical treatments, significant rise in demand for breathing devices during pandemic outbreaks, and rising number of new product launches and approvals.

The incubators, inhalators, respirators, resuscitators, and other breathing devices market analysis includes the end-user segment and geographic landscape.

The incubators, inhalators, respirators, resuscitators, and other breathing devices market is segmented as below:

By End-user

  • Healthcare settings
  • Pharmaceutical companies

By Geographical Landscape

  • Europe
  • North America
  • Asia
  • Rest of World (ROW)

This study identifies the growing advances in breathing devices as one of the prime reasons driving the incubators, inhalators, respirators, resuscitators, and other breathing devices market growth during the next few years. Also, the surge in demand for disposable devices and increasing sales of breathing devices through online sales channels will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report covers the following areas:

  • Incubators, inhalators, respirators, resuscitators, and other breathing devices market sizing
  • Incubators, inhalators, respirators, resuscitators, and other breathing devices market forecast
  • Incubators, inhalators, respirators, resuscitators, and other breathing devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, the report provides a detailed analysis of several leading incubators, inhalators, respirators, resuscitators, and other breathing devices market vendors that include 3M Co., Ambu AS, Beurer GmbH, Cardinal Health Inc., DANYANG AIRTECH Co. Ltd., Draegerwerk AG and Co. KGaA, Flexicare Group Ltd., GE Healthcare Inc., Hamilton Medical AG, Honeywell International Inc., HUM GmbH, Koninklijke Philips NV, Laerdal Medical AS, LIFE Corp., Medline Industries Inc., Medtronic Plc, Omron Healthcare Europe BV, Phoenix Medical Systems (P) Ltd., Prestige Ameritech, and Zurich Corp.. Also, the incubators, inhalators, respirators, resuscitators, and other breathing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. The analyst’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

The analyst recognizes the following companies as the key players in the global incubators, inhalators, respirators, resuscitators, and other breathing devices market: 3M Co., Ambu AS, Beurer GmbH, Cardinal Health Inc., DANYANG AIRTECH Co. Ltd., Draegerwerk AG and Co. KGaA, Flexicare Group Ltd., GE Healthcare Inc., Hamilton Medical AG, Honeywell International Inc., HUM GmbH, Koninklijke Philips NV, Laerdal Medical AS, LIFE Corp., Medline Industries Inc., Medtronic Plc, Omron Healthcare Europe BV, Phoenix Medical Systems (P) Ltd., Prestige Ameritech, and Zurich Corp.

Commenting on the report, an analyst said: ”The latest trend gaining momentum in the market is growing advances in breathing devices.”

According to the report, one of the major drivers for this market is the increasing number of hospitalizations and surgical treatments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

There are about 126,138 Veterinarians currently practicing in the United States

https://www.usatoday.com/web-stories/how-zoonotic-diseases-spread-to-humans/

Animals can sometimes carry harmful germs that can spread to people and cause illness – these are known as zoonotic diseases or zoonoses. Zoonotic diseases are caused by harmful germs like viruses, bacterial, parasites, and fungi. These germs can cause many different types of illnesses in people and animals, ranging from mild to serious illness and even death. Animals can sometimes appear healthy even when they are carrying germs that can make people sick, depending on the zoonotic disease.

Zoonotic diseases are very common, both in the United States and around the world. Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals. Because of this, CDC works 24/7 to protect people from zoonotic diseases in the United States and around the world.

Corporate , News , Posts
There are about 126,138 Veterinarians currently practicing in the United States

https://www.usatoday.com/web-stories/how-zoonotic-diseases-spread-to-humans/

Animals can sometimes carry harmful germs that can spread to people and cause illness – these are known as zoonotic diseases or zoonoses. Zoonotic diseases are caused by harmful germs like viruses, bacterial, parasites, and fungi. These germs can cause many different types of illnesses in people and animals, ranging from mild to serious illness and even death. Animals can sometimes appear healthy even when they are carrying germs that can make people sick, depending on the zoonotic disease.

Zoonotic diseases are very common, both in the United States and around the world. Scientists estimate that more than 6 out of every 10 known infectious diseases in people can be spread from animals, and 3 out of every 4 new or emerging infectious diseases in people come from animals. Because of this, CDC works 24/7 to protect people from zoonotic diseases in the United States and around the world.

Light & Dark Mode

Primary Color

Secondary Color

Layout Mode

Translate>>